| 000 | 01543 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514185010.0 | ||
| 264 | 0 | _c20040608 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.5.1904-1907.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBergshoeff, A S | |
| 245 | 0 | 0 |
_aPharmacokinetics of indinavir combined with low-dose ritonavir in human immunodeficiency virus type 1-infected children. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMay 2004 |
||
| 300 |
_a1904-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xmetabolism |
| 650 | 0 | 4 | _aHIV-1 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndinavir _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRitonavir _xadverse effects |
| 700 | 1 | _aFraaij, P L A | |
| 700 | 1 | _avan Rossum, A M C | |
| 700 | 1 | _aVerweel, G | |
| 700 | 1 | _aWynne, L H | |
| 700 | 1 | _aWinchell, G A | |
| 700 | 1 | _aLeavitt, R Y | |
| 700 | 1 | _aNguyen, B-Y T | |
| 700 | 1 | _ade Groot, R | |
| 700 | 1 | _aBurger, D M | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 5 _gp. 1904-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.5.1904-1907.2004 _zAvailable from publisher's website |
| 999 |
_c14816363 _d14816363 |
||